title: Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation.
abstract: Cell growth and proliferation require coordinated ribosomal biogenesis and translation. Eukaryotic initiation factors (eIFs) control translation at the rate-limiting step of initiation. So far, only two eIFs connect extracellular stimuli to global translation rates: eIF4E acts in the eIF4F complex and regulates binding of capped messenger RNA to 40S subunits, downstream of growth factors, and eIF2 controls loading of the ternary complex on the 40S subunit and is inhibited on stress stimuli. No eIFs have been found to link extracellular stimuli to the activity of the large 60S ribosomal subunit. eIF6 binds 60S ribosomes precluding ribosome joining in vitro. However, studies in yeasts showed that eIF6 is required for ribosome biogenesis rather than translation. Here we show that mammalian eIF6 is required for efficient initiation of translation, in vivo. eIF6 null embryos are lethal at preimplantation. Heterozygous mice have 50% reduction of eIF6 levels in all tissues, and show reduced mass of hepatic and adipose tissues due to a lower number of cells and to impaired G1/S cell cycle progression. eIF6(+/-) cells retain sufficient nucleolar eIF6 and normal ribosome biogenesis. The liver of eIF6(+/-) mice displays an increase of 80S in polysomal profiles, indicating a defect in initiation of translation. Consistently, isolated hepatocytes have impaired insulin-stimulated translation. Heterozygous mouse embryonic fibroblasts recapitulate the organism phenotype and have normal ribosome biogenesis, reduced insulin-stimulated translation, and delayed G1/S phase progression. Furthermore, eIF6(+/-) cells are resistant to oncogene-induced transformation. Thus, eIF6 is the first eIF associated with the large 60S subunit that regulates translation in response to extracellular signals.
authors.affiliation: Molecular Histology and Cell Growth Laboratory, San Raffaele Science Institute, Via Olgettina 58, 20132 Milan, Italy.
authors.forename: Valentina
authors.initials: V
authors.lastname: Gandin
authors.forename: Annarita
authors.initials: A
authors.lastname: Miluzio
authors.forename: Anna Maria
authors.initials: AM
authors.lastname: Barbieri
authors.forename: Anne
authors.initials: A
authors.lastname: Beugnet
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Kiyokawa
authors.forename: Pier Carlo
authors.initials: PC
authors.lastname: Marchisio
authors.forename: Stefano
authors.initials: S
authors.lastname: Biffo
mesh_terms: D000273:Adipose Tissue / Q000166:cytology; D000818:Animals; D001835:Body Weight; D002455:Cell Division / Q000187:drug effects; D002466:Cell Nucleolus / Q000378:metabolism; D002471:Cell Transformation, Neoplastic; D002478:Cells, Cultured; D003593:Cytoplasm / Q000378:metabolism; D005347:Fibroblasts; D016193:G1 Phase / Q000187:drug effects; D006579:Heterozygote; D007328:Insulin / Q000494:pharmacology; D008099:Liver / Q000166:cytology / Q000254:growth & development; D051379:Mice; D041681:NIH 3T3 Cells; D009857:Oncogenes / Q000235:genetics; D010442:Peptide Chain Initiation, Translational / Q000187:drug effects; D010448:Peptide Initiation Factors / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D012270:Ribosomes / Q000737:chemistry / Q000378:metabolism; D016196:S Phase / Q000187:drug effects
chemical_list: D007328:Insulin; D010448:Peptide Initiation Factors; C021019:eIF-6
references.citation: Mol Cell Biol. 2001 Mar;21(5):1453-62
references.pmid: 11238882
references.citation: Blood. 2004 Sep 1;104(5):1314-23
references.pmid: 15142884
references.citation: Mol Cell. 2001 Dec;8(6):1363-73
references.pmid: 11779510
references.citation: Oncogene. 2006 Oct 16;25(48):6416-22
references.pmid: 17041626
references.citation: Nat Cell Biol. 2002 Jul;4(7):529-33
references.pmid: 12080348
references.citation: Genes Dev. 2002 Nov 15;16(22):2923-34
references.pmid: 12435633
references.citation: Nat Rev Mol Cell Biol. 2005 Apr;6(4):318-27
references.pmid: 15803138
references.citation: J Biol Chem. 1997 Nov 28;272(48):30314-21
references.pmid: 9374518
references.citation: J Cell Biol. 1999 Mar 8;144(5):823-37
references.pmid: 10085284
references.citation: Nature. 2003 Dec 4;426(6966):579-84
references.pmid: 14654845
references.citation: Nat Rev Mol Cell Biol. 2004 Oct;5(10):827-35
references.pmid: 15459663
references.citation: Dev Biol. 1998 May 1;197(1):77-92
references.pmid: 9578620
references.citation: Nat Struct Mol Biol. 2008 Apr;15(4):346-53
references.pmid: 18345015
references.citation: J Biol Chem. 1999 Apr 23;274(17):11653-9
references.pmid: 10206977
references.citation: Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9200-5
references.pmid: 15961545
references.citation: Cell. 1997 Mar 7;88(5):593-602
references.pmid: 9054499
references.citation: Science. 2006 Oct 20;314(5798):428-9
references.pmid: 17053135
references.citation: Biochem Soc Trans. 2006 Feb;34(Pt 1):7-11
references.pmid: 16246168
references.citation: Mol Cell Biol. 1999 Feb;19(2):1416-26
references.pmid: 9891075
references.citation: Annu Rev Biochem. 2004;73:657-704
references.pmid: 15189156
references.citation: J Biol Chem. 1979 Sep 25;254(18):8796-800
references.pmid: 479160
references.citation: J Biol Chem. 1982 Jul 10;257(13):7712-9
references.pmid: 7085645
references.citation: Biochem J. 2007 Apr 15;403(2):217-34
references.pmid: 17376031
references.citation: Mol Cell Biol. 2000 Aug;20(15):5516-28
references.pmid: 10891491
references.citation: Cancer Res. 2000 Feb 1;60(3):510-6
references.pmid: 10676626
references.citation: Cell Prolif. 2007 Jun;40(3):397-410
references.pmid: 17531083
references.citation: Biochem Biophys Res Commun. 2005 Nov 11;337(1):89-94
references.pmid: 16188229
references.citation: Nature. 2007 Jun 14;447(7146):823-8
references.pmid: 17507929
references.citation: Nat Genet. 2007 Apr;39(4):486-95
references.pmid: 17353896
references.citation: Biochem J. 1980 Sep 15;190(3):615-9
references.pmid: 7008783